gp100 (420-437)

gp100 (420-437) is a synthetic peptide fragment derived from the human glycoprotein 100 (gp100) antigen, specifically corresponding to amino acid residues 420 to 437. As a well-characterized epitope, this peptide is widely recognized for its significance in immunological studies, particularly in the context of antigen processing and presentation. Its defined sequence and provenance from a melanocyte-lineage protein render it a valuable tool for dissecting T cell responses, elucidating mechanisms of immune recognition, and supporting the development of advanced immunological assays. Researchers utilize this peptide to investigate the molecular underpinnings of antigen-specific immune activity, making it a cornerstone in studies involving peptide-based immunology, T cell epitope mapping, and immune monitoring.

Epitope Mapping: The 420-437 fragment of gp100 serves as a canonical epitope for mapping CD8+ and CD4+ T cell responses in vitro. By employing this peptide in functional assays, researchers can accurately identify and characterize T cell populations that specifically recognize the gp100 antigen. This application is critical for understanding the diversity and specificity of immune repertoires, particularly in studies focusing on tumor antigen recognition and autoimmunity. The use of this defined peptide enables precise delineation of T cell reactivity and supports the development of antigen-specific immunological reagents.

Antigen Presentation Studies: The synthetic gp100 (420-437) peptide is instrumental in investigating the mechanisms of antigen processing and presentation by major histocompatibility complex (MHC) molecules. By pulsing antigen-presenting cells with this peptide, scientists can analyze the efficiency and dynamics of peptide-MHC complex formation, T cell activation thresholds, and subsequent intracellular signaling events. Such studies provide essential insights into the molecular interactions governing immune surveillance and antigen-specific cellular immunity.

Peptide-Based Assay Development: As a well-defined immunogenic sequence, gp100 (420-437) is frequently incorporated into the design of peptide-based immunoassays, including enzyme-linked immunospot (ELISpot) and intracellular cytokine staining protocols. Its use allows for the quantification and functional analysis of antigen-specific T cell responses, facilitating the evaluation of immune competence in experimental systems. The reliability and reproducibility of assays employing this peptide make it an indispensable standard in immunological research and assay validation.

Immunogenicity Assessment: Researchers leverage this peptide to assess the immunogenic potential of gp100-derived epitopes in various experimental models. By monitoring T cell activation, cytokine secretion, and proliferation in response to the peptide, investigators can systematically evaluate the factors influencing antigenicity and immune responsiveness. These studies are vital for advancing the understanding of peptide-driven immune recognition and for optimizing antigen selection in immunological research.

Peptide Functional Studies: The gp100 (420-437) fragment is also utilized in mechanistic investigations aimed at deciphering the functional consequences of antigen-specific T cell engagement. By employing this peptide in co-culture systems, scientists can study downstream effects such as cytotoxicity, cytokine production, and cellular differentiation. These functional assays are essential for elucidating the biological significance of antigen-specific interactions and for modeling immune dynamics in vitro.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

5. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation